Target intelligence / Profile preview

Collagen type XI alpha-2 chain (COL11A2)

Target
COL11A2
Molecular classification
Fibrillar collagen, Extracellular matrix protein, Structural protein, Other
01

Overview

Collagen type XI alpha-2 chain is a protein encoded by the COL11A2 gene and is a minor fibrillar collagen forming a part of type XI collagen, critical for the structure and strength of connective tissues such as cartilage, tendons, and components of the developing skeleton. It assembles together with other collagen chains—specifically pro-alpha1(XI) and pro-alpha1(II)—to form the triple-helix structure of type XI collagen, which in turn regulates fibril assembly, spacing, and the organization of type II collagen. This regulation is crucial for proper cartilage matrix formation and mechanical properties of tendons, as well as for development of various other tissues. Mutations in COL11A2 are associated with several severe skeletal and connective tissue disorders, including fibrochondrogenesis, otospondylomegaepiphyseal dysplasia, specific forms of hereditary deafness, and Stickler syndrome type III. There are currently no drugs that act specifically on this protein and it is not considered a therapeutic target in the sense of receptors, enzymes, or conventional drug targets. It is, however, important as a genetic biomarker for certain inherited skeletal and auditory disorders.

Other names
Collagen alpha-2(XI) chainCOL11A2HKE5DFNA13DFNB53FBCG2OSMEDAOSMEDBPARPSTL3pro-alpha2(XI) chain of collagen type XI
02

Mechanism of action

Not applicable (no approved drugs directly targeting COL11A2)

03

Biological functions

Regulation of collagen fibrillogenesisMaintenance of connective tissue structure and strengthSupports cartilage structureRegulates tendon fibril assembly and organization
04

Disease associations

Skeletal dysplasias (Fibrochondrogenesis type 2, otospondylomegaepiphyseal dysplasia)Nonsyndromic sensorineural hearing loss (DFNA13)Type III Stickler syndromeWeissenbacher-Zweymuller syndrome
05

Biomarkers

Pathogenic COL11A2 mutations are used in genetic testing for skeletal dysplasias and hereditary hearing loss

Beyond the preview

Go deeper on Collagen type XI alpha-2 chain (COL11A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen type XI alpha-2 chain (COL11A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call